- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.03 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1Y7: (2R,3R,4S,5R,6S)-2,3,4,5,6,7-hexahydroxyheptyl dihydrogen phosphate(Non-covalent)
- 2 x TPP: THIAMINE DIPHOSPHATE(Non-covalent)
TPP.2: 26 residues within 4Å:- Chain A: S.40, K.75, H.77, G.123, S.124, L.125, G.154, D.155, G.156, E.157, E.160, N.185, L.187, G.188, Q.189, K.244, H.258
- Chain B: D.341, T.342, I.364, E.366, F.392, R.395, Q.428
- Ligands: 1Y7.1, MG.13
17 PLIP interactions:13 interactions with chain A, 4 interactions with chain B- Hydrogen bonds: A:G.123, A:L.125, A:D.155, A:G.156, A:E.157, A:N.185, B:Q.428
- Water bridges: A:N.185, B:T.388
- Salt bridges: A:K.75, A:H.77, A:H.77, A:K.244, A:K.244, A:H.258
- Hydrophobic interactions: B:F.392
- pi-Stacking: B:F.392
TPP.18: 26 residues within 4Å:- Chain A: D.341, T.342, I.364, E.366, F.392, R.395, Q.428
- Chain B: S.40, K.75, H.77, G.123, S.124, L.125, G.154, D.155, G.156, E.157, E.160, N.185, L.187, G.188, Q.189, K.244, H.258
- Ligands: 1Y7.17, MG.29
16 PLIP interactions:3 interactions with chain A, 13 interactions with chain B- Hydrophobic interactions: A:F.392
- Hydrogen bonds: A:Q.428, B:G.123, B:L.125, B:D.155, B:G.156, B:E.157, B:N.185
- pi-Stacking: A:F.392
- Water bridges: B:N.185
- Salt bridges: B:K.75, B:H.77, B:H.77, B:K.244, B:K.244, B:H.258
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 7 residues within 4Å:- Chain A: Q.127, A.131, S.371, V.374, Q.399, M.402, A.403
Ligand excluded by PLIPEDO.4: 4 residues within 4Å:- Chain A: L.92, D.106, L.107, Q.115
Ligand excluded by PLIPEDO.5: 8 residues within 4Å:- Chain A: L.158, S.159, W.164
- Chain B: W.164, E.165, A.168, F.209
- Ligands: EDO.9
Ligand excluded by PLIPEDO.6: 2 residues within 4Å:- Chain A: N.590, R.591
Ligand excluded by PLIPEDO.7: 7 residues within 4Å:- Chain A: R.21, S.25, A.84, A.87, E.88, E.94, L.97
Ligand excluded by PLIPEDO.8: 5 residues within 4Å:- Chain A: Q.189, S.256, W.257, H.258
- Chain B: N.344
Ligand excluded by PLIPEDO.9: 8 residues within 4Å:- Chain A: L.158, S.159, W.164, L.195, Y.202, R.205
- Chain B: F.209
- Ligands: EDO.5
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: Y.564, L.587, A.588, N.590
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: F.71, V.72, L.73, L.82, F.117, T.118
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain A: P.63, N.68, D.69, R.70, F.71, W.86, R.379
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain A: E.423, G.596, K.597
- Chain B: A.33, R.101, K.102
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain A: Y.563, Y.564, E.565, V.589, N.590
- Chain B: K.538
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain B: Q.127, A.131, S.371, V.374, Q.399, M.402, A.403
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain B: L.92, D.106, L.107, Q.115
Ligand excluded by PLIPEDO.21: 8 residues within 4Å:- Chain A: W.164, E.165, A.168, F.209
- Chain B: L.158, S.159, W.164
- Ligands: EDO.25
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain B: N.590, R.591
Ligand excluded by PLIPEDO.23: 7 residues within 4Å:- Chain B: R.21, S.25, A.84, A.87, E.88, E.94, L.97
Ligand excluded by PLIPEDO.24: 5 residues within 4Å:- Chain A: N.344
- Chain B: Q.189, S.256, W.257, H.258
Ligand excluded by PLIPEDO.25: 8 residues within 4Å:- Chain A: F.209
- Chain B: L.158, S.159, W.164, L.195, Y.202, R.205
- Ligands: EDO.21
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain B: Y.564, L.587, A.588, N.590
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain B: F.71, V.72, L.73, L.82, F.117, T.118
Ligand excluded by PLIPEDO.28: 7 residues within 4Å:- Chain B: P.63, N.68, D.69, R.70, F.71, W.86, R.379
Ligand excluded by PLIPEDO.30: 6 residues within 4Å:- Chain A: A.33, R.101, K.102
- Chain B: E.423, G.596, K.597
Ligand excluded by PLIPEDO.32: 6 residues within 4Å:- Chain A: K.538
- Chain B: Y.563, Y.564, E.565, V.589, N.590
Ligand excluded by PLIP- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.13: 4 residues within 4Å:- Chain A: D.155, N.185, L.187
- Ligands: TPP.2
3 PLIP interactions:2 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.155, A:L.187, H2O.18
MG.29: 4 residues within 4Å:- Chain B: D.155, N.185, L.187
- Ligands: TPP.18
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.155, B:L.187, H2O.48
- 2 x NA: SODIUM ION(Non-functional Binders)
NA.15: 4 residues within 4Å:- Chain A: N.411, A.461, T.464, C.468
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.411, A:T.464, A:T.464
NA.31: 4 residues within 4Å:- Chain B: N.411, A.461, T.464, C.468
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.411, B:A.461, B:T.464
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ludtke, S. et al., Sub-angstrom-resolution crystallography reveals physical distortions that enhance reactivity of a covalent enzymatic intermediate. Nat Chem (2013)
- Release Date
- 2013-08-21
- Peptides
- Transketolase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.03 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1Y7: (2R,3R,4S,5R,6S)-2,3,4,5,6,7-hexahydroxyheptyl dihydrogen phosphate(Non-covalent)
- 2 x TPP: THIAMINE DIPHOSPHATE(Non-covalent)
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ludtke, S. et al., Sub-angstrom-resolution crystallography reveals physical distortions that enhance reactivity of a covalent enzymatic intermediate. Nat Chem (2013)
- Release Date
- 2013-08-21
- Peptides
- Transketolase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A